ITCI
Neuberger Berman Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-318,782
| Closed | -$42.1M | – | 2130 |
|
|
2025
Q1 | $42.1M | Buy |
318,782
+230,395
| +261% | +$30.4M | 0.04% | 465 |
|
|
2024
Q4 | $7.38M | Buy |
88,387
+1,117
| +1% | +$93.3K | 0.01% | 868 |
|
|
2024
Q3 | $6.39M | Sell |
87,270
-9,044
| -9% | -$662K | 0.01% | 880 |
|
|
2024
Q2 | $6.6M | Buy |
96,314
+14,498
| +18% | +$993K | 0.01% | 848 |
|
|
2024
Q1 | $5.66M | Buy |
81,816
+25,965
| +46% | +$1.8M | ﹤0.01% | 895 |
|
|
2023
Q4 | $4M | Buy |
55,851
+49,607
| +794% | +$3.55M | ﹤0.01% | 963 |
|
|
2023
Q3 | $325K | Buy |
6,244
+378
| +6% | +$19.7K | ﹤0.01% | 1570 |
|
|
2023
Q2 | $371K | Buy |
5,866
+454
| +8% | +$28.7K | ﹤0.01% | 1528 |
|
|
2023
Q1 | $293K | Buy |
5,412
+1,152
| +27% | +$62.4K | ﹤0.01% | 1604 |
|
|
2022
Q4 | $225K | Buy |
+4,260
| New | +$225K | ﹤0.01% | 1668 |
|
|
2016
Q1 | – | Sell |
-7,500
| Closed | -$403K | – | 1530 |
|
|
2015
Q4 | $403K | Buy |
+7,500
| New | +$403K | ﹤0.01% | 1320 |
|